Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039794 | SCV000063483 | benign | not specified | 2012-04-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039794 | SCV000170580 | benign | not specified | 2014-03-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000230295 | SCV000291173 | benign | Hypertrophic cardiomyopathy 1 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000230295 | SCV002048986 | benign | Hypertrophic cardiomyopathy 1 | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004716912 | SCV005315015 | benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030333 | SCV000053000 | benign | Cardiomyopathy | 2015-06-04 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000039794 | SCV001930552 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039794 | SCV001956946 | benign | not specified | no assertion criteria provided | clinical testing |